The Nuffield Department of Clinical Medicine is part of the Medical Sciences Division. It hosts one of the largest groupings of biomedical researchers in the University sector, and is also responsible for a significant part of the teaching of clinical medical students within the Oxford Medical School.
Researchers are invited to a major Wellcome visit. Professor Jim Smith, Wellcome Director of Science, will lead a session where he will update and seek input on his plans to develop a science funding strategy. Three parallel workshops will follow for Early Career Researchers, Innovation, and Humanities and Social Sciences. Fri 26 May at the Small Lecture Theatre, Sherrington Building.
Protection from the most severe form of malaria is linked with natural variation in human red blood cell genes. Led by Professor Dominic Kwiatkowski, researchers from the Wellcome Trust Centre for Human Genetics and the Wellcome Trust Sanger Institute have identified a genetic rearrangement of red blood cell glycophorin receptors that confers a 40% reduced risk from severe malaria.
May 18th is World AIDS Vaccine Day. In partnership with European and African researchers, Professor Tomáš Hanke is leading a programme to advance a HIV vaccine candidate designed to prevent infection throughout the world. Visit the GREAT website, launched today.
A new £115 million biomedical research centre has opened at Oxford University’s Old Road campus in Headington. With the support of a £20 million donation from the Li Ka Shing Foundation, the Li Ka Shing Centre for Health Information and Discovery will bring together researchers to analyse biomedical data from across the world. It aims to help improve understanding of diseases and the development of new treatments for conditions including cancer and Alzheimer’s.
WWARN is a network of research that analyses pooled data of numerous clinical trials. The sheer size of those data sets allows study groups to answer questions that couldn't be asked of a normal size clinical trial, such as the efficacy of an anti-malarial drug on malnourished or severely anaemic children. This research helps design policies to maintain the efficacy of current anti-malaria drugs, currently threatened by growing resistance, as explained by Dr Georgina Humphreys.
Thu 25 May 1-2pm
Lecture Theatre 1
Haematology: "Tracking cancer through treatment to improve outcome – using Acute Myeloid Leukaemia as an examplar: opportunities and challenges for the NHS", Prof Paresh Vyas
Psychological Medicine: "Enforced treatment; medicine and the law", Dr Michael Yousif
Chair: Prof Chris Conlon